Spermatogenesis in Testicles with Germ Cell Tumors

Igal Shpunt1, Dan Leibovici1, Sergey Ikher2

  • 1Department of Urology, Kaplan Medical Center, Rehovot, Israel.

Abstract

Insights

Ipsilateral fertility (IF) is present in nearly half of patients undergoing radical orchiectomy for germ-cell tumors (GCT). Maximal tumor diameter (MTD) does not predict IF, supporting routine pre-orchiectomy sperm banking.

Area of Science:

  • Reproductive Medicine
  • Oncology
  • Urology

Background:

  • Germ-cell tumors (GCT) significantly impact male fertility, with subfertility affecting nearly 50% of patients.
  • Fertility can be further compromised by GCT treatments, necessitating fertility preservation strategies like sperm banking before radical orchiectomy.
  • The contribution of the affected testis to fertility remains uncertain, highlighting the need for predictive markers.

Purpose of the Study:

  • To investigate the correlation between maximal tumor diameter (MTD) and ipsilateral fertility (IF) in patients treated for GCT.
  • To assess the prevalence of ipsilateral fertility in patients undergoing orchiectomy for GCT.

Main Methods:

  • Retrospective review of 57 GCT patients undergoing orchiectomy (1999-2015) for demographic and clinical data.
  • Assessment of spermatogenesis (full, hypospermatogenesis, absence) and presence of mature epididymal spermatozoa.
  • Definition of IF as full spermatogenesis (>100 tubules) and presence of mature epididymal spermatozoa; Mann-Whitney test used for MTD correlation analysis.

Main Results:

  • Ipsilateral fertility (IF) was observed in 28 out of 57 patients (49%).
  • No statistically significant correlation was found between maximal tumor diameter (MTD) and ipsilateral fertility (IF).
  • Full spermatogenesis was present in 57.8% and mature epididymal spermatozoa in 82.7% of patients.

Conclusions:

  • Ipsilateral fertility (IF) is present in approximately half of patients undergoing radical orchiectomy for GCT.
  • Maximal tumor diameter (MTD) is not a reliable predictor of ipsilateral fertility (IF).
  • Routine sperm banking prior to radical orchiectomy is recommended due to the unpredictability of fertility status.

Related Concept Videos

Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
123.0K
Spermatogenesis01:22

Spermatogenesis

Spermatogenesis is a complex process that involves the development of sperm cells from undifferentiated stem cells in the seminiferous tubules of the testes. The process is essential for the production of mature and functional sperm cells that are capable of fertilizing an egg.
The process of spermatogenesis can be divided into mitosis, meiosis, and spermiogenesis. During mitosis, the spermatogonia or stem cells divide to produce two identical daughter cells, type A and B spermatogonia. Type-A...
9.6K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.8K